Evidence map›Paper›PMID 26712930›Full record

ReviewJournal of cutaneous medicine and surgery2016

Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.

April W Armstrong, Lakshi Aldredge, Paul S Yamauchi

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cutaneous medicine and surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Recommendations for Initiating Systemic Therapy in Patients with Psoriasis.The Journal of clinical and aesthetic dermatology · 2019
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

April W ArmstrongDepartment of Dermatology, University of Colorado Denver, Aurora, CO, USA aprilarmstrong@post.harvard.edu.
Lakshi AldredgeDepartment of Dermatology, Portland Veterans Affairs Medical Center, Portland, OR, USA.
Paul S YamauchiDermatology Institute and Skin Care Center, Santa Monica, CA, USA Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Portland VA Medical Center · USUniversity of California, Los Angeles · USUniversity of Colorado Denver · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psoriasis is a common inflammatory disease with significant comorbidities, whose management can be challenging given the variety of treatment options. It is critical for nurse practitioners, physician assistants, general practitioners, and dermatology trainees to have useful information about the treatment and monitoring of patients with psoriasis. Although certain aspects of care apply to all patients, each therapeutic agent has its own nuances in terms of assessments, dosing, and monitoring. The most appropriate treatment is based not only on disease severity but also on comorbid conditions and concomitant medications. These practitioners are vital in facilitating patient care by thorough understanding of systemic agents, selection criteria, dosing, and recommended monitoring. This article provides high-yield practical pearls on managing patients with moderate to severe psoriasis. It includes case-based discussions illustrating considerations for special populations, such as pregnant women, children, and patients with comorbidities (eg, human immunodeficiency virus infection, hepatitis C, hepatitis B, and history of malignancy).

Indexed as

AcitretinAnti-Inflammatory Agents, Non-SteroidalBiological ProductsCyclosporineDisease ProgressionHumansImmunosuppressive AgentsInsurance, Health, ReimbursementKeratolytic AgentsMedication AdherenceMethotrexatePsoriasisSymptom Flare UpThalidomideAcitretinAnti-Inflammatory Agents, Non-SteroidalapremilastBiological ProductsCyclosporineImmunosuppressive AgentsKeratolytic AgentsMethotrexateThalidomidebiologicscyclosporinemethotrexatepsoriasisTNF inhibitor

Identifiers

PMID26712930
PMCPMC4834511
OpenAlexW2208104866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.